Percutaneous transluminal angioplasty against arteriosclerosis obliterans in dialysis patients

被引:0
作者
Tsuchida, K
Takemoto, Y
Sugimura, K
Yoshimura, R
Nakatani, T
机构
[1] Osaka City Univ, Sch Med, Dept Urol, Abeno Ku, Osaka 5458586, Japan
[2] Osaka City Univ, Sch Med, Div Artificial Kidney, Abeno Ku, Osaka 5458586, Japan
关键词
percutaneous transluminal angioplasty; arteriosclerosis obliterans; hemodialysis;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The incidence of peripheral arteriosclerosis is on the increase in chronic hemodialysis patients. Recently, the intervention (IV) treatment is conducted to deal with this problem. IV was performed in 4 dialysis patients against the complication of arteriosclerosis obliterans (ASO) but the result was unsuccessful in 3 of them. These 3 failure cases were investigated to find the problems associated with percutaneous transluminal angioplasty (PTA). Cases 1, 2 and 3 had intermittent claudication while case 4 had gangrenous toes as the major complaint. The symptoms in these cases were attributable to 90-100% stenosis and occlusion of superficial femoral artery, bilateral iliac arteries, bilateral superficial femoral-popliteal artery, branch of right iliac artery and left iliac artery region, respectively. IV was successful in case I but failed in cases 2 and 4 because the catheter itself did not go through due to the severe stenosis of vessel or the procedure of forcefully dilating the vessel caused dispersion of minute thrombi. In case 3, acute myocardial infarction occurred at 10 h after successful IV, resulting in sudden death. In view of the extent of invasion, IV is a treatment method selected against ASO in dialysis patients. However, the method has a high risk of causing thrombus formation, vessel rupture and organ failure. In this regard, it is advisable to evaluate the systemic condition and conduct IV if the extent of stenosis is mild.
引用
收藏
页码:365 / 368
页数:4
相关论文
共 10 条
  • [1] Atherosclerosis risk factors related to hemodialysis duration and erythropoietin therapy
    Dejanova, B
    Filipce, V
    Dejanov, P
    Sikole, A
    Grozdanovski, R
    Maleska, V
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (06) : 484 - 486
  • [2] Eberhardt R T, 2000, Heart Dis, V2, P62
  • [3] GERARD M, 1997, KIDNEY INT, V51, P1678
  • [4] Graor R A, 1992, Cardiovasc Clin, V22, P217
  • [5] LDL apheresis for arteriosclerosis obliterans with occluded bypass graft: Change in prostacyclin and effect on ischemic symptoms
    Mii, S
    Mori, A
    Sakata, H
    Nakayama, M
    Tsuruta, H
    [J]. ANGIOLOGY, 1998, 49 (03) : 175 - 180
  • [6] Fifteen-year experience in axillofemoral bypass with externally supported knitted dacron prosthesis in a Japanese hospital
    Mii, S
    Mori, A
    Sakata, H
    Kawazoe, N
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 186 (05) : 581 - 588
  • [7] NAKAI S, 2002, J JPN SOC DIAL THER, V35, P1155
  • [8] Lower limb amputation for diabetic foot
    Ohsawa, S
    Inamori, Y
    Fukuda, K
    Hirotuji, M
    [J]. ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2001, 121 (04) : 186 - 190
  • [9] Onohara T, 1999, PANMINERVA MED, V41, P1
  • [10] Report on the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996
    Shinzato, T
    Nakai, S
    Akiba, T
    Yamagami, S
    Yamazaki, C
    Kitaoka, T
    Kubo, K
    Maeda, K
    Morii, H
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (02) : 700 - 712